Editorials
Limited efficacy of targeted treatments in Sjögren’s syndrome: why?
A.G. Tzioufas1, A.V. Goules2
- Pathophysiology Department, Athens School of Medicine, Athens, Greece. agtzi@med.uoa.gr
- Pathophysiology Department, Athens School of Medicine, Athens, Greece.
CER11304
2018 Vol.36, N°3 ,Suppl.112
PI 0027, PF 0028
Editorials
Free to view
(click on article PDF icon to read the article)
PMID: 29998826 [PubMed]
Received: 05/04/2018
Accepted : 24/04/2018
In Press: 21/06/2018
Published: 12/08/2018
